WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002028416) PREVENTIVES/REMEDIES FOR HEMOLYTIC ANEMIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/028416    International Application No.:    PCT/JP2001/008572
Publication Date: 11.04.2002 International Filing Date: 28.09.2001
Chapter 2 Demand Filed:    23.04.2002    
IPC:
A61K 38/36 (2006.01)
Applicants: MOCHIDA PHARMACEUTICAL CO., LTD. [JP/JP]; 7, Yotsuya 1-chome Shinjuku-ku, Tokyo 160-8515 (JP) (For All Designated States Except US).
HOSAKA, Yoshitaka [JP/JP]; (JP) (For US Only).
MATSUMOTO, Miwa [JP/JP]; (JP) (For US Only).
IMADA, Kazunori [JP/JP]; (JP) (For US Only)
Inventors: HOSAKA, Yoshitaka; (JP).
MATSUMOTO, Miwa; (JP).
IMADA, Kazunori; (JP)
Agent: HANABUSA, Tsuneo; c/o Hanabusa Patent Office Shin-Ochanomizu Urban Trinity 2, Kandasurugadai 3-chome Chiyoda-ku, Tokyo 101-0062 (JP)
Priority Data:
2000-338308 30.09.2000 JP
Title (EN) PREVENTIVES/REMEDIES FOR HEMOLYTIC ANEMIA
(FR) TRAITEMENTS PREVENTIFS/REMEDES ASSOCIES A L'ANEMIE HEMOLYTIQUE
Abstract: front page image
(EN)Hemolysis inhibitors and preventives/remedies for hemolytic anemia characterized by containing a thrombomodulin-like protein as the active ingredient. Highly safe medicinal compositions which are applicable to hemolysis caused by various factors as, in particular, preventives/remedies for acquired hemolytic anemia, remain stable in vivo, exhibit a long-lasting effect and show little side effect.
(FR)L'invention concerne des inhibiteurs de l'hémolyse et de traitements préventifs/remèdes associés à l'anémie hémolytique, caractérisés en ce qu'ils contiennent une protéine de type thrombomoduline en tant qu'ingrédient actif. Selon la présente invention, des compositions médicinales d'une grande innocuité, pouvant être appliquées à l'hémolyse provoquée par divers facteurs, telles que notamment des traitements préventifs/remèdes associés à l'anémie hémolytique acquise, restent stables in vivo, ont un effet de longue durée et très peu d'effets secondaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)